6-8
Oct
2026
AqVida GmbH
About AqVida GmbH
Certifications
-
FDA -
GMP
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:2
-
Employees:50 - 99
Company types
Contact info
-
-
-
Kaiser-Wilhelm-Str. 89, D-20355 , Hamburg, Germany
Products from AqVida GmbH (12)
-
Product Azathioprine AqVida film-coated tablets
25 mg, 50 mg Tablets Immunosuppressant -
Product Docetaxel AqVida 20 mg/ml concentrate for solution for infusion
20 mg, 80 mg, 140 mg, 160 mg vial Indications: Treatment of breast cancer, special form of lung cancer, prostate cancer, gastric cancer and head or neck cancer -
Product Epirubicin AqVida 2 mg/ml solution for injection
10 mg, 20 mg, 50 mg, 100 mg, 200 mg vialIndications: Treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, bladder cancer -
Product Gemcitabine AqVida 38 mg/ml powder for solution for infusion
200 mg, 1 g, 2 g vial Indications: Treatment of NSCLC, pancreatic cancer, bladder cancer, breast cancer -
Product Imatinib AqVida hard capsules*
100 mg, 200 mg, 400 mg capsuleIndications: Treatment of chronic myeloid leukaemia, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement. -
Product Irinotecan AqVida 20 mg/ml concentrate for solution for infusion
40 mg, 100 mg, 300 mg vial Indications: Treatment of advanced colorectal cancer -
Product Oxaliplatin AqVida 5 mg/ml concentrate for solution for infusion
50 mg, 100 mg, 200 mg vial
Indications: Treatment of advanced colorectal cancer -
Product Paclitaxel AqVida 6 mg/ml concentrate for solution for infusion
30 mg, 100 mg, 150 mg, 300 mg vial Indications: Treatment of ovarian cancer, breast cancer, advanced NSCLC, AIDS-related Kaposi‘s sarcoma -
Product Sunitinib AqVida hard capsules*
12.5 mg, 25 mg, 37.5 mg, 50 mg CapsuleIndications: Treatment of mRCC, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement. -
Product Azacitidin AqVida 25 mg/ml concentrate for solution for infusion
Filling Sizes: 100 mg; 150 mg
-
Product Bendamustine AqVida 100 mg/ml concentrate for solution for infusion
Filling Sizes: 50 mg/ 0,5 ml; 100 mg/ 1 ml; 200 mg/ 2 ml
-
Product Cabazitaxel AqVida 20 mg/ml concentrate for solution for infusion*
Filling Size: 0 mg/3 ml
* Products that are subject to current patent protection are not offered in countries in which sale constitutes a patent infringement.
